GB202107222D0 - Method of treg isolation - Google Patents

Method of treg isolation

Info

Publication number
GB202107222D0
GB202107222D0 GBGB2107222.8A GB202107222A GB202107222D0 GB 202107222 D0 GB202107222 D0 GB 202107222D0 GB 202107222 A GB202107222 A GB 202107222A GB 202107222 D0 GB202107222 D0 GB 202107222D0
Authority
GB
United Kingdom
Prior art keywords
treg isolation
treg
isolation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2107222.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quell Therapeutics Ltd
Original Assignee
Quell Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quell Therapeutics Ltd filed Critical Quell Therapeutics Ltd
Priority to GBGB2107222.8A priority Critical patent/GB202107222D0/en
Publication of GB202107222D0 publication Critical patent/GB202107222D0/en
Ceased legal-status Critical Current

Links

GBGB2107222.8A 2021-05-20 2021-05-20 Method of treg isolation Ceased GB202107222D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2107222.8A GB202107222D0 (en) 2021-05-20 2021-05-20 Method of treg isolation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2107222.8A GB202107222D0 (en) 2021-05-20 2021-05-20 Method of treg isolation

Publications (1)

Publication Number Publication Date
GB202107222D0 true GB202107222D0 (en) 2021-07-07

Family

ID=76637812

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2107222.8A Ceased GB202107222D0 (en) 2021-05-20 2021-05-20 Method of treg isolation

Country Status (1)

Country Link
GB (1) GB202107222D0 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851341A (en) 1986-12-19 1989-07-25 Immunex Corporation Immunoaffinity purification system
US5506121A (en) 1992-11-03 1996-04-09 Institut Fur Bioanalytik Gemeinnutzige Gesellschaft MBH Fusion peptides with binding activity for streptavidin
US6103493A (en) 1996-10-10 2000-08-15 Institut Fur Bioanalytic Streptavidin muteins
WO2019241549A1 (en) 2018-06-15 2019-12-19 A2 Biotherapeutics, Inc. Foxp3-expressing car-t regulatory cells

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851341A (en) 1986-12-19 1989-07-25 Immunex Corporation Immunoaffinity purification system
US5506121A (en) 1992-11-03 1996-04-09 Institut Fur Bioanalytik Gemeinnutzige Gesellschaft MBH Fusion peptides with binding activity for streptavidin
US6103493A (en) 1996-10-10 2000-08-15 Institut Fur Bioanalytic Streptavidin muteins
WO2019241549A1 (en) 2018-06-15 2019-12-19 A2 Biotherapeutics, Inc. Foxp3-expressing car-t regulatory cells

Non-Patent Citations (15)

* Cited by examiner, † Cited by third party
Title
"Remington's Pharmaceutical Sciences", MACK PUBLISHING CO.
BRENTJENS ET AL., CCR, vol. 13, 15 September 2007 (2007-09-15), pages 5426 - 35
CASUCCI ET AL., BLOOD, vol. 122, no. 20, 14 November 2013 (2013-11-14), pages 3461 - 72
IMAI C, LEUKEMIA, vol. 18, no. 4, April 2004 (2004-04-01), pages 676 - 84
LIU ET AL., JEM, vol. 7, no. 10, 2006, pages 1701 - 1711
LOPES, J.E. ET AL., THE JOURNAL OF IMMUNOLOGY, vol. 177, no. 5, 2006, pages 3133 - 3142
LOZANO, T. ET AL., FRONTIERS IN ONCOLOGY, vol. 3, 2013, pages 294
MAHER ET AL., NAT BIOTECHNOL, vol. 20, no. 1, January 2002 (2002-01-01), pages 70 - 5
MEKALA ET AL., BLOOD, vol. 105, 2005, pages 2090 - 2092
MILONE ET AL., MOL THER, vol. 17, no. 8, August 2009 (2009-08-01), pages 1453 - 64
POLANSKY, J.K. ET AL., EUROPEAN JOURNAL OF IMMUNOLOGY, vol. 38, no. 6, 2008, pages 1654 - 1663
PULE ET AL., MOL THER, vol. 12, no. 5, November 2005 (2005-11-01), pages 933 - 41
SAVOLDO B, BLOOD, vol. 113, no. 25, 18 June 2009 (2009-06-18), pages 6392 - 402
SIEGLER ET AL., ANNU. REV. IMMUNOL., vol. 24, 2006, pages 209 - 26
SONG, X. ET AL., CELL REPORTS, vol. 1, no. 6, 2012, pages 665 - 675

Similar Documents

Publication Publication Date Title
EP4052784A4 (en) Method for producing polyhydroxyalkanoate and use of same
IL282058A (en) Engineering of dnase enzymes for manufacturing and therapy
EP3874055C0 (en) Enzymatic method for preparation of udp-galactose
GB202011367D0 (en) Method of preparing liposomes
GB202200070D0 (en) Method of culture
EP3696168A4 (en) Method for preparation of 2-chloro-5-trifluoromethylpyridine
EP3766874A4 (en) Preparation method for hexahydrofuro-furan-ol derivative and intermediate of derivative and preparation method therefor
EP3886353A4 (en) Apparatus for time synchronization of relay apparatus and method therefor
GB202000926D0 (en) Method of diagnosis
GB202107222D0 (en) Method of treg isolation
GB202007476D0 (en) Method of treg isolation
GB202307533D0 (en) Method of treg isolation
GB202207414D0 (en) Method of treg isolation
ZA202005380B (en) Method for isolation of cytisine
IL289433A (en) Method of reconstituting liposomal annamycin
GB2592616B (en) Method of forming an article
GB201917698D0 (en) A method of isolating exosomes
GB202106258D0 (en) Method of formulation
GB202006949D0 (en) Method of formulation
GB202109679D0 (en) Method of propulsion
EP3941700A4 (en) System for and method of manufacturing hemp products
GB202006547D0 (en) Method of isolating circulating nuccleosomes
AU2021903734A0 (en) Method of cardioprotection
GB2602912B (en) Method of packaging
GB202314560D0 (en) Methods of isolating exosomes

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)